{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:21:23Z","timestamp":1782836483065,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CCSG P30 CA44579"],"award-info":[{"award-number":["CCSG P30 CA44579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA135358"],"award-info":[{"award-number":["R01CA135358"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bmcl.2017.05.077","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T20:16:08Z","timestamp":1496088968000},"page":"3472-3476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Initial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma"],"prefix":"10.1016","volume":"27","author":[{"given":"Tao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna B.","family":"Banizs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.05.077_b0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3420249","article-title":"Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions","volume":"342","author":"D'Amours","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2017.05.077_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2017.05.077_b0015","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/annonc\/mdw094","article-title":"PARP inhibitors in ovarian cancer","volume":"27","author":"Ledermann","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bmcl.2017.05.077_b0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1947601910383418","article-title":"Upregulation of poly (ADP-ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types","volume":"1","author":"Ossovskaya","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bmcl.2017.05.077_b0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/annonc\/mdr361","article-title":"Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer","volume":"23","author":"Rojo","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bmcl.2017.05.077_b0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.22141","article-title":"PARP1 expression in pediatric central nervous system tumors","volume":"53","author":"Barton","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bmcl.2017.05.077_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4081\/ejh.2012.e9","article-title":"PARP-1 protein expression in glioblastoma multiforme","volume":"56","author":"Galia","year":"2012","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.bmcl.2017.05.077_b0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.humpath.2005.04.017","article-title":"Poly (adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region","volume":"36","author":"Staibano","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bmcl.2017.05.077_b0045","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1021\/jm8001263","article-title":"4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly (ADP-ribose) polymerase-1","volume":"51","author":"Menear","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.077_b0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cmdc.201000426","article-title":"High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors","volume":"6","author":"Keliher","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2017.05.077_b0055","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/anie.201006579","article-title":"Synthesis and in vivo imaging of a 18F-labeled PARP1 inhibitor using a chemically orthogonal scavenger-assisted high-performance method","volume":"50","author":"Reiner","year":"2011","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"10.1016\/j.bmcl.2017.05.077_b0060","doi-asserted-by":"crossref","DOI":"10.1593\/neo.12414","article-title":"Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents","volume":"14","author":"Reiner","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.bmcl.2017.05.077_b0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s11307-015-0858-0","article-title":"Dual-modality optical\/PET imaging of PARP1 in glioblastoma","volume":"17","author":"Carlucci","year":"2015","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.bmcl.2017.05.077_b0070","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neo.2014.05.005","article-title":"PARPi-FL-a fluorescent PARP1 inhibitor for glioblastoma imaging","volume":"16","author":"Irwin","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.bmcl.2017.05.077_b0075","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.biomaterials.2010.11.073","article-title":"The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma","volume":"32","author":"Iyer","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bmcl.2017.05.077_b0080","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1158\/0008-5472.CAN-10-3484","article-title":"Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas","volume":"71","author":"Iyer","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2017.05.077_b0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jcmm.12000","article-title":"PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT\/mTOR axis via SIRT1","volume":"17","author":"Pinton","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmcl.2017.05.077_b0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.addr.2010.09.007","article-title":"Radiopharmaceutical chemistry for positron emission tomography","volume":"62","author":"Li","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2017.05.077_b0095","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1073\/pnas.93.13.6814","article-title":"Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu","volume":"93","author":"Connett","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2017.05.077_b0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.nucmedbio.2016.08.007","article-title":"Iodinated benzimidazole PARP radiotracer for evaluating PARP1\/2 expression in vitro and in vivo","volume":"43","author":"Anderson","year":"2016","journal-title":"Nucl Med Biol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17305759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17305759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:19:39Z","timestamp":1760771979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17305759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0960894X17305759"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.077","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}